| PERIOD ENDING | 3-Jan-09 | 29-Dec-07 | 30-Dec-06 | | Total Revenue | 67,011 | 100,060 | 151,448 | | Cost of Revenue | 59,460 | 91,261 | 129,181 | | | Gross Profit | 7,551 | 8,799 | 22,267 | | | Operating Expenses | | Research Development | 6,871 | 4,748 | 3,315 | | Selling General and Administrative | 12,929 | 15,900 | 9,191 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (12,249) | (11,849) | 9,761 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 336 | 411 | (24) | | Earnings Before Interest And Taxes | (11,913) | (11,438) | 9,737 | | Interest Expense |
-
|
-
| 1,825 | | Income Before Tax | (11,913) | (11,438) | 7,912 | | Income Tax Expense | 3,301 | (4,025) | 2,844 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (15,214) | (7,413) | 5,068 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (15,214) | (7,413) | 5,068 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($15,214) | ($7,413) | $5,068 |
|
1.48% Nasdaq 
Income Statement
